Good afternoon, and welcome to Vir Biotechnology's conference call to discuss the company's VIR-5500 Strategic Collaboration with Astellas and Positive Phase I Data, and 2025 financial results. As a ...
Joining me on today's call from Vir Biotechnology, Inc., are Dr. Marianne De Backer, our Chief Executive Officer, Dr. Mark D.
Discover how Monte Carlo analysis helps investors assess risk and make informed decisions. Explore its role in generating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results